Dementia and neuroprogressive conditions will be the focus of discussions in the USA this week as representatives from NHS Research Scotland travel to Boston. Supported by Scottish Development International, the NHS Research Scotland delegation will meet with research and development leads from leading pharmaceutical companies to match expertise and capability in Scotland with current drug pipelines. It builds upon Scotland’s ambition to increase the level of...
Scotland is at the heart of recent advances in data-driven healthcare and precision medicine. We often hear that healthcare stands on the threshold of its precision medicine future. In many ways the future has already arrived. A third of new drugs approved by the United States Food & Drug Administration in 2017 were precision, or personalised, medications, according to the Personalized Medicine Coalition. However, many...
The key to preventing age-related cancers may lie in the body’s own immune system, new research suggests. Scientists at the University of Dundee found an ageing immune system could be a stronger reason for developing cancer compared with genetic mutation. They said the discovery could have “major implications” for the fight against the disease. The team, which also included researchers from Heriot Watt University, the...
Exscientia, LegoChem Biosciences, 4P-Pharma, Beacon Discovery, Sigilon Therapeutics and Unum Therapeutics, were selected from more than 150 applicants for their commitment to cutting-edge science in emerging areas of research. Elsevier highlighted that all six companies demonstrate significant potential to impact how future treatments are researched and developed. As members of The Hive, each company will receive support, complimentary training and access to Elsevier’s suite of information...
From Alexander Fleming to John Stenlake, Scotland has an illustrious history of drug discovery. Find out why these five firms are at the cutting edge of the pharmaceutical sector in Scotland. Scotland has always been at the forefront of drug discovery and the impact made by its scientists and universities has been felt worldwide. Landmark discoveries include anesthesia, penicillin and atracurium. More recently, Scotland is leading...
Symbiosis’s underlying positive growth trend has continued, and aligns well with their strategic focus on developing the business in the North American market alongside their more established client base in Europe. Their efforts to proactively build relationships with biotech companies in the U.S. has been a resounding success. The Symbiosis team has also grown by 30% this year, ensuring they have been able to service...